John Evans Net Worth & Insider Trades
John Evans - CEO, Beam Therapeutics Inc
What is John Evans's Net Worth?
The current estimated net worth of Beam Therapeutics Inc's CEO, John Evans, is estimated to be about $57.72M . John Evans owns about 103,000 units of Beam Therapeutics Inc common stock. In the last 2 years at Beam Therapeutics Inc, John Evans has sold an estimated value of $20.21M worth.
What is John Evans's Past Insider Trading?
John Evans's largest purchase order was 59,450 units , worth over $137.04K on May 2, 2022. John Evans's largest sale order was 47,700 units , worth over $4M on October 8, 2021. In total, John Evans has made about 13 transactions over 2 years of their time at Beam Therapeutics Inc. John Evans usually trades in April, with the busiest year in 2021. The most recent transaction was a sale order of 50,000 units , worth over $2.32M on November 2, 2022.
John Evans
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was John Evans's Salary in 2020?
As CEO of Beam Therapeutics Inc, John Evans has a total base salary of $529,271 . John Evans received compensation valued at about $906,768 in 2020 after becoming CEO. The vast majority of their compensation came in the form of other earnings, plans or compensations of $9,684 , other earnings, plans or compensations of $9,684 , and other earnings, plans or compensations of $9,684 .
What is John Evans's' Mailing Address?
- Mailing address is C/o Beam Therapeutics Inc. 26 Landsdowne Street Cambridge MA 02139 MA
Beam Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Total
|
|---|---|---|---|---|---|---|
| John Evans | 2020 | $529,271 | $9,684 | $9,684 | $9,684 | $906,768 |
| John Evans | 2019 | $472,500 | $1,034 | $1,034 | $1,034 | $2,209,800 |
| Giuseppe Ciaramella, Ph.D. | 2020 | $469,363 | $9,684 | $9,684 | $9,684 | $6,852,786 |
| Giuseppe Ciaramella, Ph.D. | 2019 | $413,502 | $18,948 | $18,948 | $18,948 | $1,588,450 |
| Terry-Ann Burrell | 2020 | $420,000 | $53,752 | $53,752 | $53,752 | $683,752 |
| Terry-Ann Burrell | 2019 | $147,180 | $54,058 | $54,058 | $54,058 | $4,302,723 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1745999/000156459021020335/beam-def14a_20210609.htm
What are Beam Therapeutics Inc's Past Insider Trades?
Beam Therapeutics Inc's most recent insider trade came on January 30, 2023 by Terryann Burrell who sold 37,254 units worth $1.68M . In the last 3 years, insiders at Beam Therapeutics Inc have sold an estimated value of $58.56M and bought an estimated value of $5.14M worth of shares. Insider trading is most common in April, with the busiest year in 2021. The most active traders at the company are Giuseppe Ciaramella, President & CSO, John Evans, CEO, and Terryann Burrell, Chief Financial Officer .
Beam Therapeutics Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||